Last update 07 Jun 2025

TFX06

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TFX 06, TFX-06, TFX06
Target
ER
Action
degraders
Mechanism
ERs degraders(Estrogen receptors degraders)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Advanced breast cancerER-positive/HER2-negative Breast CancerMetastatic breast cancer
Inactive Indication-
Originator Organization
Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
Active Organization
Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TFX06
NCT05927779
/ RecruitingPhase 1/2
Phase I/II Clinical Study to Evaluate the Safety, Tolerance, Efficacy and Pharmacokinetics of TFX06 Tablet in ER Positive, HER Negative Locally Advanced or Metastatic Breast Cancer.
100 Clinical Results associated with TFX06
Login to view more data
100 Translational Medicine associated with TFX06
Login to view more data
100 Patents (Medical) associated with TFX06
Login to view more data
100 Deals associated with TFX06
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced breast cancerPhase 2
China
Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
17 Apr 2023
ER-positive/HER2-negative Breast CancerPhase 2
China
Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
17 Apr 2023
Metastatic breast cancerPhase 2
China
Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free